Comment from Ingram Jeremy
AnonymousSupportIndividual
Summary: The commenter is an individual demanding the approval of ANKTIVA to save lives and improve the U.S. biosector. They argue that the agency is prioritizing pharmaceutical profits over patient needs and call for faster regulatory action.
It is a shame that we have to write on a comment section to get ANKTIVA approved to actually save lives. Why you guys sit on your hands and worry about profits over patients there’s people out here truly making a difference. The United States is absolutely getting destroyed in bio sector and it’s all because of your lack of approvals. It suggests that you’re in big Pharma‘s pocket and it’s very easy to see. Immunity Bio is American as it gets. We demand approval.